Quantcast

CorNova to Present at the Glimpse into the Future: Emerging Drug-Eluting Stents Symposium at EuroPCR 2009

May 14, 2009

S. Eric Ryan, M.D., Will Discuss the Valecor Platinum(TM) Coronary Stent System on the FiberHalo(TM) Balloon Angioplasty Catheter

BURLINGTON, Mass., May 14 /PRNewswire/ — CorNova Inc. today announced S. Eric Ryan, M.D., the company’s chairman and chief executive officer, will present the Valecor Platinum(TM) Coronary Stent on the FiberHalo(TM) Balloon Angioplasty Catheter at the Glimpse into the Future: Emerging Drug-Eluting Stents symposium during EuroPCR 2009 in Barcelona, Spain. The symposium will begin at 1:30 p.m. on Thursday, May 21, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO )

About CorNova

CorNova is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time and patient risk. The FiberHalo(TM) stent deployment catheter will enable the physician to deploy the stent and measure in-stent lumen area during the procedure. The FiberHalo(TM) post-dilatation catheter will be able to correct for any under-expansion and also measure post-dilatation results. CorNova is also developing a pre-dilatation version of the FiberHalo(TM) that will be able to obtain information on arterial plaque composition, allowing for better physician decision-making, and the Valecor Platinum(TM) stent, a bare-metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury, that has shown superior performance and anti-restenosis properties compared to current bare-metal stents. For more information, visit www.cornova.com.

SOURCE CorNova Inc.


Source: newswire



comments powered by Disqus